UNSPSC 51341902: Zinviroxime

This classification denotes an antiviral agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9SWB3P2O2S. European Medicines Agency schedules Zinviroxime in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00166MIG. Zinviroxime generally arises in the molecular formula C17H18N4O3S.

UNSPSC 51341902 Zinviroxime (Commodity) does not reflect the pharmaceutical and medical supply work actually being solicited by state and local government bodies under this code. Recent opportunities tagged to this code cover naloxone and drug deactivation systems, medical and first aid supplies for emergency response, generic multi-source pharmaceuticals distributed through authorized wholesalers, and direct-to-manufacturer prescription programs—none of which align with zinviroxime as a specific antiviral or pharmaceutical compound. The mismatch suggests either a tagging error in the source data or a fundamental misalignment between the code's nominal scope and current purchasing activity. No recent solicitations directly reference zinviroxime or match its clinical profile, indicating minimal or no current state and local procurement demand for this specific product.

The geographic spread of opportunities tagged to this code spans Florida (Seminole County), Texas (Texas Health and Human Services Commission), Minnesota (MMCAP, serving multiple states including Oregon), and Florida (City of Tampa), though the substance of these solicitations covers unrelated pharmaceutical and medical supply categories rather than the code's stated product. Without evidence of active demand for zinviroxime specifically, this code presents limited pursuit opportunity for vendors specializing in that product line.